For the current quarter, analysts are expecting Valeant Pharmaceuticals International, Inc. (NYSE:VRX) to report EPS of $N/A. This consensus estimate is provided by Zacks Research. After the period that ended on N/A, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported an EPS actual of $N/A. The difference between the actual and estimate resulted in a surprise factor of N/A%. The company is expected to release their next earnings report on or around N/A. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.
Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) have a current ABR or average broker rating of N/A. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.
Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is $N/A. The top analyst target is $N/A, and the lowest target is $N/A on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.
According to data provided by Zacks Research, The Coca-Cola Co (NYSE:KO) has a consensus target price of $45.375 on the stock. Out of the polled analysts providing targets, the high is currently $50, while the low is resting at $42. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting The Coca-Cola Co (NYSE:KO) to post a current quarter EPS of $0.57. This consensus number is compiled by Zacks Research. For the period ending on 2017-03-31, the company reported EPS for the quarter of $0.43. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was -2.27%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-07-26.
In terms of analyst ratings, The Coca-Cola Co (NYSE:KO) has a current ABR of 2.67. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.